Provides startup funding or seed money for a new investigator conducting clinical and/or social research on the prevention of musculoskeletal youth sports injuries
RFA Release Date - 11/15/2025 LOI Deadline - N/A Application Deadline - 2/16/2026
Successful proposals clearly advance orthopaedic clinical care, including:
Trauma, fracture healing, biomechanics
Osteoarthritis and cartilage preservation
Tendon/ligament repair, sports medicine
Spine and back disorders
Orthopaedic oncology (primary bone/soft tissue tumors)
Orthopaedic infection and musculoskeletal immunity
Pediatric orthopaedics
Joint arthroplasty / prosthesis outcomes
Orthobiologics and regenerative therapies
Pain management / opioid-sparing strategies
Implant innovations & wear reduction
❗ Generic musculoskeletal biology or basic science ≤ no clear clinical trajectory = typically not competitive.
Each mechanism has different expectations:
| Mechanism | Ideal Applicant | Strong Predictors |
|---|---|---|
| Career Development Grants | Early-career faculty | Preliminary data + trajectory → NIH K/R |
| New Investigator Grants | First independent funding | Feasibility + mentorship + innovation |
| Resident/Medical Student Grants | Trainees | Mentorship + achievable pilot data |
| Focused/Partnership Grants (AAOS, MTF, Zimmer Biomet, ON Foundation, etc.) | Subspecialty researchers | Topic fit (trauma, joint preservation, spine) |
| Clinician–Scientist Development Awards | Surgeons with research track | Protected time + training plan |
Predictor: Clearly match career stage + deliverables to the selected mechanism.
Even pilot proposals benefit from:
Feasibility evidence (assays, models, patient access)
Proof-of-concept biomechanics or animal study results
Preliminary clinical registry or health services data
A clear signal supporting the central hypothesis
Predictor: Preliminary data ≈ top predictor of funding success.
OREF emphasizes translatability, so top applications use:
Patient-derived samples or clinical imaging
Relevant large-animal models for orthopaedics
Biomechanics testing & validated implants
Registry/claims/outcomes datasets
Real-world patient-reported outcomes
Predictor: Human or near-human relevance is weighted heavily.
OREF grants are often 1–2 years → scope must be realistic.
Strong proposals:
Have 2–3 tightly focused aims
Include measurable milestones and statistics plans
Provide go/no-go criteria + alternatives
Link Aims to future NIH or DOD funding
Predictor: Feasibility and clarity strongly influence scoring.
For early-career mechanisms, reviewers look for:
Orthopaedic-focused publication record
Independence from mentor’s work
Clear vision for a sustainable orthopaedic research career
Professional involvement (AAOS, subspecialty societies)
Predictor: Convincing potential to become a future research leader.
Especially critical for trainees and junior faculty:
Mentor with R01-level funding and orthopaedic expertise
Institutional support (protected time, facilities)
Access to motion labs, imaging centers, tissue/mechanical testing cores
Predictor: Strong environment → high reviewer confidence.
Including:
Musculoskeletal injury prevention
Reducing revision surgeries & implant failure
Limb salvage and post-trauma quality of life
Pain control without opioids
Disparities and access in orthopaedic care
Return-to-function and mobility preservation
Predictor: Clear patient-benefit narrative increases impact score.
OREF values cross-disciplinary excellence:
Surgeon + biomechanist teams
Orthopaedics + rehabilitation sciences
Engineering partnerships
Health services + data science collaborations
Predictor: Demonstrated collaborative synergy strengthens proposals.
Funded applications are:
Concise, visually clear, and logically structured
Rich in figures/tables to show feasibility
Explicit about statistical methods and rigor
Compliant with page limits, formatting, and deadlines
Predictor: Well-written grants consistently score higher.
| Predictor | Why It Matters |
|---|---|
| Orthopaedic patient benefit | Core mission |
| Mechanism alignment | Ensures proper scope & expectations |
| Preliminary data | Feasibility confidence |
| Clinically relevant models | Translational value |
| Focused Aims | Fit 1–2-year timeline |
| Investigator trajectory | Future research leadership |
| Mentorship & environment | Execution confidence |
| Alignment with orthopaedic priorities | Boosts impact |
| Collaboration | Enhances scientific strength |
| Strong writing & rigor | Influences reviewer enthusiasm |
Applications may be submitted by domestic and Canadian, non-profit, public and private institutions of higher education, such as hospitals, medical schools, universities, and colleges. An orthopaedic surgeon licensed to practice in the United States may serve as Principal Investigator (PI) or co-PI. Multidisciplinary research activity is always encouraged. PhDs and DVMs may serve as the principal investigator (PI) if S/he has a primary or secondary faculty appointment in an orthopaedic department.
Sponsor Institute/Organizations: Orthopaedic Research and Education Foundation
Sponsor Type: Corporate/Non-Profit
Address: 9400 W. Higgins Road, Suite 320, Rosemont, IL 60018
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Feb 16, 2026
Feb 16, 2026
$25,000
Affiliation: Orthopaedic Research and Education Foundation
Address: 9400 W. Higgins Road, Suite 320, Rosemont, IL 60018
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.